Search Results - Bob Wilffert

Refine Results
  1. 1
    Pharmacogenetics of isoniazid-induced hepatotoxicity

    Pharmacogenetics of isoniazid-induced hepatotoxicity by Dyah Aryani Perwitasari, Jarir At Thobari, Bob Wilffert

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    The use of ketamine to cope with depression and post-traumatic stress disorder: A qualitative analysis of the discourses posted on a popular online forum

    The use of ketamine to cope with depression and post-traumatic stress disorder: A qualitative analysis of the discourses posted on a popular online forum by Tharcila V. Chaves, Bob Wilffert, Zila M. Sanchez

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Overdoses and deaths related to the use of ketamine and its analogues: a systematic review

    Overdoses and deaths related to the use of ketamine and its analogues: a systematic review by Tharcila V. Chaves, Bob Wilffert, Zila M. Sanchez

    Published 2022
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Pharmacogenetics of drug–drug interaction and drug–drug–gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6

    Pharmacogenetics of drug–drug interaction and drug–drug–gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6 by Muh. Akbar Bahar, Didik Setiawan, Eelko Hak, Bob Wilffert

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon

    Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon by J. R. B. J. Brouwers, Tom Schalekamp, Bob Wilffert, Maarten J. Beinema

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Clinical response to antipsychotic drug treatment: Association study of polymorphisms in six candidate genes

    Clinical response to antipsychotic drug treatment: Association study of polymorphisms in six candidate genes by Jelle Vehof, Huibert Burger, Bob Wilffert, Asmar Al Hadithy, Behrooz Z. Alizadeh, Harold Snieder

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Association between Adherence to Guideline-Recommended Preventive Medications and In-Hospital Mortality among Non-Reperfused ST-Elevation Myocardial Infarction Patients Admitted to a Tertiary Care Academic Center in a Developing Country

    Association between Adherence to Guideline-Recommended Preventive Medications and In-Hospital Mortality among Non-Reperfused ST-Elevation Myocardial Infarction Patients Admitted to... by Sylvi Irawati, Surya Dharma, Katja Taxis, Thắng Nguyễn, Nunung Nursyarofah, Bob Wilffert, Eelko Hak

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC-MS/MS

    A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolit... by E.J.J. Berm, J. Paardekooper, E. Brummel-Mulder, Eelko Hak, Bob Wilffert, Jan Gerard Maring

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    The association between the <i>NAT2</i> genetic polymorphisms and risk of DILI during anti‐TB treatment: a systematic review and meta‐analysis

    The association between the <i>NAT2</i> genetic polymorphisms and risk of DILI during anti‐TB treatment: a systematic review and meta‐analysis by Min Zhang, Shuqiang Wang, Bob Wilffert, Rongsheng Tong, Dick van Soolingen, Susan van den Hof, Jan‐Willem C. Alffenaar

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature

    Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature by E.J.J. Berm, Margot de Looff, Bob Wilffert, Cornelis Boersma, Lieven Annemans, Stefan Vegter, Job F. M. van Boven, Maarten J. Postma

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis

    Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis by Noor Alsaad, Bob Wilffert, Richard van Altena, Wiel C.M. de Lange, Tjip S. van der Werf, Jos G.W. Kosterink, Jan‐Willem C. Alffenaar

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery

    Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery by Jan Peter Yska, Eric N. van Roon, Anthonius de Boer, Hubert G. M. Leufkens, Bob Wilffert, Loek J. M. de Heide, Frank de Vries, Arief Lalmohamed

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis

    Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis by Marlanka A. Zuur, Mathieu S. Bolhuis, Richard Anthony, Alice den Hertog, Tridia van der Laan, Bob Wilffert, Wiel de Lange, Dick van Soolingen, Jan‐Willem C. Alffenaar

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study

    P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study by Nur Aizati Athirah Daud, Jorieke E. H. Bergman, Marian K. Bakker, Hao Wang, Wilhelmina S. Kerstjens‐Frederikse, Hermien E. K. de Walle, Henk Groen, Jens H. J. Bos, Eelko Hak, Bob Wilffert

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients

    Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients by Innokentiy S. Losenkov, Nathaniël J. V. Mulder, Л. А. Левчук, N. Vyalova, A.J.M. Loonen, Fokko J. Bosker, Г. Г. Симуткин, Anastasiia S. Boiko, Н. А. Бохан, Bob Wilffert, Eelko Hak, Amand F. Schmidt, Svetlana А. Ivanova

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    NMDA receptor genotypes associated with the vulnerability to develop dyskinesia

    NMDA receptor genotypes associated with the vulnerability to develop dyskinesia by Svetlana А. Ivanova, A.J.M. Loonen, Petros Pechlivanoglou, Maxim B. Freidin, A.F.Y. Al Hadithy, E.V. Rudikov, Irina Zhukova, Н. В. Говорин, В.А. Сорокина, Olga Fedorenko, В. М. Алифирова, A. Semke, J. R. B. J. Brouwers, Bob Wilffert

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Pharmacogenetic Information in Clinical Guidelines: The European Perspective

    Pharmacogenetic Information in Clinical Guidelines: The European Perspective by Jesse J. Swen, Marga Nijenhuis, Mandy van Rhenen, Nienke J. de Boer‐Veger, Anne‐Marie Buunk, Elisa J. F. Houwink, Hans Mulder, Gerard A. Rongen, Ron H. N. van Schaik, Jan van der Weide, Bob Wilffert, Vera H.M. Deneer, Henk‐Jan Guchelaar

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)

    Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone) by Maja Matić, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer‐Veger, Anne‐Marie Buunk, Elisa J. F. Houwink, Hans Mulder, Gerard A. Rongen, Jan van der Weide, Bob Wilffert, Jesse J. Swen, Henk‐Jan Guchelaar, Vera H.M. Deneer, Ron H. N. van Schaik

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs

    Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs by J. Brouwer, Marga Nijenhuis, Bianca Soree, Henk‐Jan Guchelaar, Jesse J. Swen, Ron H. N. van Schaik, Jan van der Weide, Gerard A. Rongen, Anne‐Marie Buunk, Nienke J. de Boer‐Veger, Elisa J. F. Houwink, Roos van Westrhenen, Bob Wilffert, Vera H.M. Deneer, Hans Mulder

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines

    Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines by Carin A.T.C. Lunenburg, Cathelijne H. van der Wouden, Marga Nijenhuis, Mandy H. Crommentuijn-van Rhenen, Nienke J. de Boer‐Veger, Anne M. Buunk, Elisa J. F. Houwink, Hans Mulder, Gerard A. Rongen, Ron H. N. van Schaik, Jan van der Weide, Bob Wilffert, Vera H.M. Deneer, Jesse J. Swen, Henk‐Jan Guchelaar

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: